Примери за използване на Dispersible tablets на Английски и техните преводи на Български
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Cartons contain 56 dispersible tablets.
The dispersible tablets are dispersed by stirring in a glass of water
The dispersible tablets and the new film-coated tablets are to be taken once a day,
Bioavailability of film-coated tablets is higher than of the dispersible tablets and the strength of film-coated tablets is correspondingly lower.
The dispersible tablets are to be mixed with a liquid to make up a suspension that the patient can drink.
All references to the dispersible tablet formulation throughout the SmPC refer to the reference medical product dispersible tablets.
Consistently take only the tablets or only the dispersible tablets, and never a combination of both.
iron overload, treatment with deferasirox dispersible tablets was assessed in a 1-year,
At a starting dose of 10 mg/kg/day, deferasirox dispersible tablets led to reductions in indicators of total body iron.
If you are switching from dispersible tablets to the new film-coated tablets,
Ucedane dispersible tablets are rod-shaped, white, and biconvex with three
The dispersible tablets should be taken on an empty stomach(at least 30 minutes before food),
the dose of the film-coated tablets should be 30% lower than the dose of the dispersible tablets, rounded to the nearest whole tablet. .
the dose of the granules should be 30% lower than the dose of the dispersible tablets, rounded to the nearest whole sachet.
The most frequent reactions reported during chronic treatment in clinical studies conducted with deferasirox dispersible tablets in adult and paediatric patients include gastrointestinal disturbances(mainly nausea,
On average, serum ferritin decreased by 222.0 µg/l in patients treated with deferasirox dispersible tablets(starting dose 10 mg/kg/day)
In a healthy volunteer study, the concomitant administration of deferasirox dispersible tablets and midazolam(a CYP3A4 probe substrate)
The most frequent reactions reported during chronic treatment with deferasirox dispersible tablets in adult and paediatric patients include gastrointestinal disturbances(mainly nausea,
In a healthy volunteer study, the concomitant administration of deferasirox dispersible tablets and midazolam(a CYP3A4 probe substrate)
In study AC-052-373(FUTURE 3), using dispersible tablets, the exposure to bosentan in the patients treated with 2 mg/kg twice daily was comparable to that in the FUTURE 1 study.